Table 3.
Studies included in the meta-analysis for the correlation between the serum AQP4-IgG titer and the Expanded Disability Status Scale (EDSS) score.
First author, year | No. of patients | Age | Ethnicity | AQP4-IgG test method | Diagnosis | Diagnostic criteria | Tx | n | r |
---|---|---|---|---|---|---|---|---|---|
Liang, 2019 (26) | 97 | 42+ | Chinese | CBA-IFI | NMOSD | 2015a | na | 65 | 0.30** |
Li, 2013 (21) | 16 | 41++ | Chinese | CBA-IFI | NMO | 2006b | None | 9 | 0.90* |
Isobe, 2012 (29) | 29 | 49.3+ | Japanese | CBA-FACS | NMO | 1999c | None | 18 | 0.31** |
AQP4, aquaporin4; CBA, cell-based assay; EDSS, Expanded Disability Status Scale; FACS, fluorescence-activated cell sorting; IFI, indirect immunofluorescence; NMO, neuromyelitis optica; NMOSD, neuromyelitis optica spectrum disorder; n, number of samples; na, not available; r, correlation coefficient value; Tx, treatment.
Indicates mean value;
Indicates median value.
Indicates Pearson correlation coefficient value.
Indicates Spearman correlation coefficient value.
Wingerchuk et al., (5).
Wingerchuk et al. (1).
Wingerchuk et al. (3).